[Breaking News] Single Dose Janssen Vaccine Passes Primary Verification... "Preventive Effect Confirmed"
[Asia Economy Reporter Chunhee Lee] The Janssen COVID-19 vaccine was recognized for its preventive efficacy required for approval in the first expert advisory meeting held domestically.
Hot Picks Today
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
The verification advisory panel judged that the Janssen vaccine has the preventive efficacy necessary for approval based on the results of multinational Phase 3 clinical trials conducted in eight countries, including the United States. They also considered the adverse events that occurred to be at an acceptable level.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.